1 year return (CAGR)
279.07%
AN2 Therapeutics Inc Exchange (NASDAQ, USD)
ANTX
4.88
+0.06 (+1.24%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-28.86%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
184.53M
Price/Sales
-
Ent value
145.97M
Price/Book
2.43
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
3.75%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.77 |
| Daily high | 5.06 |
| Daily low | 4.72 |
| Daily Volume | 259K |
| All-time high | 22.29 |
| 1y analyst estimate | 9.00 |
| Beta | -0.99 |
| EPS (TTM) | -0.81 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 1 Apr 2026 |
Downside potential
Loading...
Downside potential data
| ANTX | S&P500 | |
| Current price drop from All-time high | -78.11% | -0.84% |
| Highest price drop | -95.60% | -56.47% |
| Date of highest drop | 16 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -69.36% | -10.68% |
| Avg time to new high | 103 days | 12 days |
| Max time to new high | 1032 days | 1805 days |
News
